SCHEMBL7106444

SCHEMBL7106444

CCOC(=O)CCN(CCCC(C)=O)C(=O)OC(C)(C)C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA14 Q9ULX7 1/20 0.42
CYP1A2 P05177 2/20 0.37
HDAC6 Q9UBN7 2/20 0.36
HDAC1 Q13547 1/20 0.36
HDAC2 Q92769 1/20 0.36
ALOX5 P09917 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.35
GAA P10253 2/20 0.33
NFKB1 P19838 1/20 0.33
NFKB2 Q00653 1/20 0.33
RELA Q04206 1/20 0.33
MGAM O43451 1/20 0.32
SI P14410 1/20 0.32
MGAM2 Q2M2H8 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32
HTT P42858 1/20 0.32
CYP4F2 P78329 2/20 0.31
CYP4A11 Q02928 2/20 0.31
RAB9A P51151 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1272960 0.91 CA14 (0.49) CA14CYP1A2HDAC6HDAC1HDAC2
SCHEMBL7456183 0.90 CA14 (0.40) CA14CYP1A2HDAC6HDAC1HDAC2
SCHEMBL29285429 0.90 CA14 (0.47) CA14CYP1A2HDAC6HDAC1HDAC2
SCHEMBL6538907 0.87 CA14 (0.46) CA14CYP1A2HDAC6HDAC1HDAC2
SCHEMBL20045144 0.85 CA14 (0.39) CA14CYP1A2HDAC6HDAC1HDAC2
SCHEMBL15312506 0.85 SMN1; SMN2 (0.38) CA14CYP1A2HDAC6HDAC1HDAC2
SCHEMBL5786967 0.84 CA12 (0.37) CA14CYP1A2HDAC6HDAC1HDAC2
SCHEMBL6538656 0.82 CA14 (0.39) CA14CYP1A2HDAC6HDAC1HDAC2
SCHEMBL7974410 0.80 CA14 (0.36) CA14CYP1A2HDAC6HDAC1HDAC2
SCHEMBL16727726 0.80 CA14 (0.53) CA14HDAC6HDAC1HDAC2L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1044001-A4 INTEGRIN RECEPTOR ANTAGONISTS MERCK & CO INC (US) 2003-01-29 EP disclosed
EP-1044001-A1 INTEGRIN RECEPTOR ANTAGONISTS Merck & Co., Inc. (US) 2000-10-18 EP disclosed
WO-1999030713-A1 INTEGRIN RECEPTOR ANTAGONISTS MERCK & CO., INC. (US) 1999-06-24 WO disclosed